Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy.

Stefan E EngBenjamin BasasieAlfonso LamO John SemmesDean A TroyerGeoffery D ClarkeAbhijit G SunnapwarRobin J LeachTeresa L Johnson-PaisLori J SokollDaniel W ChanJeffrey J TosoianJaved SiddiquiArul M ChinnaiyanIan M ThompsonPaul C Boutros Michael A Liss

Published in: Prostate cancer and prostatic diseases (2022)

RSI-MRI, PIRADS, and PHI could improve the predictive ability to detect upgrading in AS. The strongest predictor of clinically significant prostate cancer on AS biopsy was RSI-MRI signal output.

Keyphrases

prostate cancer
contrast enhanced
magnetic resonance imaging
radical prostatectomy
ultrasound guided
diffusion weighted imaging
fine needle aspiration
high resolution
computed tomography
magnetic resonance
benign prostatic hyperplasia
mass spectrometry